Search

everythinglearnresearchcommunity

for

Search:↓

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Special cells can help regrow hair in alopecia areata.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Females generally have stronger immune responses than males due to the X chromosome.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Human hair follicles have a scent receptor that can influence hair growth.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.